4.8 (320) · € 3.99 · En stock
A team of researchers affiliated with institutions in Denmark, Germany and Hong Kong has found that several extracts from the artemisia annua plant are active against the SARS-CoV-2 virus under laboratory conditions. In their paper published in the journal Scientific Reports, the group describes three extracts of the artemisia annua plant they tested and how they fared in combating the SARS-CoV-2 virus in human lung tissue. While the main focus of the pandemic has in recent months become the vaccines that are effective for prevention of COVID-19, work continues on treatments for those unvaccinated people who become infected with the SARS-CoV-2 virus.
Artemisia annua L. hot-water extracts show potent activity in vitro against Covid-19 variants including delta - ScienceDirect
Phenolic compounds versus SARS-CoV-2: An update on the main findings against COVID-19 - ScienceDirect
Frontiers A Computational Approach to Elucidate the Interactions of Chemicals From Artemisia annua Targeted Toward SARS-CoV-2 Main Protease Inhibition for COVID-19 Treatment
Instant determination of the artemisinin from various Artemisia annua L. extracts by LC‐ESI‐MS/MS and their in‐silico modelling and in vitro antiviral activity studies against SARS‐CoV‐2 - Dogan - 2022 - Phytochemical Analysis
Artemisia annua L. extracts inhibit the in vitro replication of SARS-CoV-2 and two of its variants
Artemisia plant extracts show potential anti-SARS-CoV-2 activity in vitro
Phytocompounds of Rheum emodi, Thymus serpyllum, and Artemisia annua Inhibit Spike Protein of SARS-CoV-2 Binding to ACE2 Receptor: In Silico Approach
Antiviral Phytocompounds Against Animal-to-Human Transmittable SARS-CoV-2
Life, Free Full-Text
In vitro efficacy of Artemisia extracts against SARS-CoV-2, Virology Journal